December 2022
Sickle Cell Syndromes
Sophie Lanzkron and Jane Little, Editors
In the modern era, we have begun to understand how to lessen the risk from homozygous sickle cell disease (SCD) and have seen a welcome expansion in young adults who are surviving childhood, enjoying a longer life, but yet still face significant morbidity and early mortality. This series is an update from the expert sickle cell community about our understanding of the pathophysiology, complications, and treatments of the disease. The series addresses the myriad of complexities in organ function and how to better understand quality of life, in order to provide the reader a broad view through which to approach those affected by SCD.